Document is current

Article History

Received: 11 March 2022

Accepted: 29 August 2022

First Online: 2 September 2022

Declarations

:

: The study was approved by the Juntendo University Hospital, Independent Ethics Committee (no. 20-243) and adhered to the tenets of the Declaration of Helsinki.

: Not applicable.

: AllerSearch was created using Apple’s ResearchKit (Cupertino, CA, USA). TIn and YO are the owners of InnoJin, Inc., Tokyo, Japan who developed AllerSearch. TIn reports grants and personal fees from Santen Pharmaceutical, personal fees from InnoJin, grants from Johnson & Johnson Vision Care, Hogy Medical, Seed, Novartis Pharma, Rohto Pharmaceutical, Hoya, Ribomic, Kowa, Lion, outside the submitted work. YO reports personal fees from InnoJin, outside the submitted work. AM reports grants from Santen Pharmaceutical, Seed, Senju Pharmaceutical, Otsuka Pharmaceutical, AMO Japan, grants from Hoya, Alcon Pharmaceuticals, Eisai., Alcon Japan, Residence Building Management, Kowa Company, Novartis Pharma, Rohto Pharmaceutical, outside the submitted work. The rest of the authors have no conflicts of interest to declare.